OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15674-15674
Open Access | Times Cited: 8
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15674-15674
Open Access | Times Cited: 8
Showing 8 citing articles:
Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis
S. Yonezawa, Takayuki Haruki, Keiichi Koizumi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1570-1570
Open Access | Times Cited: 5
S. Yonezawa, Takayuki Haruki, Keiichi Koizumi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1570-1570
Open Access | Times Cited: 5
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements
Zhen Wang, Yanqi Song, Honglei Guo, et al.
Current Treatment Options in Oncology (2025)
Closed Access
Zhen Wang, Yanqi Song, Honglei Guo, et al.
Current Treatment Options in Oncology (2025)
Closed Access
The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs
Xixi Wan, Yu Tian, Tao Yu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Xixi Wan, Yu Tian, Tao Yu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis
Dan Wu, Feiqing Wang, Xu Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Dan Wu, Feiqing Wang, Xu Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Immune Therapies in AL Amyloidosis—A Glimpse to the Future
Arnon Haran, Iuliana Vaxman, Moshe E. Gatt, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1605-1605
Open Access | Times Cited: 2
Arnon Haran, Iuliana Vaxman, Moshe E. Gatt, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1605-1605
Open Access | Times Cited: 2
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting
Noopur Raje, Adam D. Cohen, Krina K. Patel, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. 350-357
Closed Access | Times Cited: 1
Noopur Raje, Adam D. Cohen, Krina K. Patel, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. 350-357
Closed Access | Times Cited: 1
Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
Francisco Cézar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 360-360
Open Access
Francisco Cézar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 360-360
Open Access
Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy
Carolyn Shasha, David R. Glass, Ernest Moelhman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Carolyn Shasha, David R. Glass, Ernest Moelhman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
